Annexin Pharmaceuticals AB (publ) (ANNX.ST)

SEK 0.43

(-1.61%)

Gross Profit Summary of Annexin Pharmaceuticals AB (publ)

  • Annexin Pharmaceuticals AB (publ)'s latest annual gross profit in 2023 was -193 Thousand SEK , down 0.0% from previous year.
  • Annexin Pharmaceuticals AB (publ)'s latest quarterly gross profit in 2024 Q2 was - SEK , up 100.0% from previous quarter.
  • Annexin Pharmaceuticals AB (publ) reported a annual gross profit of -193 Thousand SEK in annual gross profit 2022, down -0.52% from previous year.
  • Annexin Pharmaceuticals AB (publ) reported a annual gross profit of -192 Thousand SEK in annual gross profit 2021, up 0.52% from previous year.
  • Annexin Pharmaceuticals AB (publ) reported a quarterly gross profit of - SEK for 2024 Q2, up 100.0% from previous quarter.
  • Annexin Pharmaceuticals AB (publ) reported a quarterly gross profit of - SEK for 2024 Q3, down 0.0% from previous quarter.

Annual Gross Profit Chart of Annexin Pharmaceuticals AB (publ) (2023 - 2014)

Historical Annual Gross Profit of Annexin Pharmaceuticals AB (publ) (2023 - 2014)

Year Gross Profit Gross Profit Growth
2023 -193 Thousand SEK 0.0%
2022 -193 Thousand SEK -0.52%
2021 -192 Thousand SEK 0.52%
2020 -193 Thousand SEK 0.0%
2019 -193 Thousand SEK 0.0%
2018 -193 Thousand SEK 59.54%
2017 -477 Thousand SEK -532.94%
2016 -75.36 Thousand SEK 84.92%
2015 -499.69 Thousand SEK -31.44%
2014 -380.16 Thousand SEK 0.0%

Peer Gross Profit Comparison of Annexin Pharmaceuticals AB (publ)

Name Gross Profit Gross Profit Difference
Alligator Bioscience AB (publ) -160.68 Million SEK 99.88%
Ziccum AB (publ) -23.28 Million SEK 99.171%
Modus Therapeutics Holding AB (publ) - SEK Infinity%
BioArctic AB (publ) 346.31 Million SEK 100.056%
Sprint Bioscience AB (publ) 41.78 Million SEK 100.462%
Mendus AB (publ) 28.48 Million SEK 100.678%
Genovis AB (publ.) 54 Million SEK 100.357%
Intervacc AB (publ) -13.79 Million SEK 98.601%
QuiaPEG Pharmaceuticals Holding AB (publ) 2.17 Million SEK 108.89%
Active Biotech AB (publ) -1.67 Million SEK 88.478%
Magle Chemoswed Holding AB (publ) 9.96 Million SEK 101.937%
Bio-Works Technologies AB (publ) 26.82 Million SEK 100.72%
Aptahem AB (publ) 2.63 Million SEK 107.337%
Vicore Pharma Holding AB (publ) -3.42 Million SEK 94.358%
Kancera AB (publ) -1.96 Million SEK 90.178%
Infant Bacterial Therapeutics AB (publ) 77 Thousand SEK 350.649%
Fluicell AB (publ) 1.73 Million SEK 111.105%
Saniona AB (publ) 11.78 Million SEK 101.638%
Lipigon Pharmaceuticals AB (publ) -5.11 Million SEK 96.228%
Biovica International AB (publ) 6.87 Million SEK 102.806%
Spago Nanomedical AB (publ) -23.28 Million SEK 99.171%
AcouSort AB (publ) 8.38 Million SEK 102.301%
Xintela AB (publ) 78 Thousand SEK 347.436%
Abliva AB (publ) -35.66 Million SEK 99.459%
Egetis Therapeutics AB (publ) -146.9 Million SEK 99.869%
Karolinska Development AB (publ) 2.8 Million SEK 106.876%
OncoZenge AB (publ) 3000.00 SEK 6533.333%
Amniotics AB (publ) -1.93 Million SEK 90.0%
2cureX AB (publ) -37.48 Million SEK 99.485%
CombiGene AB (publ) -21.29 Million SEK 99.094%
Asarina Pharma AB (publ) -423 Thousand SEK 54.374%
Calliditas Therapeutics AB (publ) 1.12 Billion SEK 100.017%
Camurus AB (publ) 1.58 Billion SEK 100.012%
Corline Biomedical AB 28.38 Million SEK 100.68%
IRLAB Therapeutics AB (publ) -122.73 Million SEK 99.843%
Isofol Medical AB (publ) -34.41 Million SEK 99.439%
I-Tech AB 27.56 Million SEK 100.7%
Hansa Biopharma AB (publ) 70.95 Million SEK 100.272%
Cyxone AB (publ) 2.61 Million SEK 107.392%
ExpreS2ion Biotech Holding AB (publ) 3.4 Million SEK 105.671%
Biosergen AB -456 Thousand SEK 57.675%
Cantargia AB (publ) -3.45 Million SEK 94.407%
NextCell Pharma AB -43.74 Million SEK 99.559%
Xspray Pharma AB (publ) -9.19 Million SEK 97.901%
Elicera Therapeutics AB (publ) 11.21 Million SEK 101.72%
Nanologica AB (publ) -76 Thousand SEK -153.947%
SynAct Pharma AB -778 Thousand SEK 75.193%
Stayble Therapeutics AB (publ) - SEK Infinity%
LIDDS AB (publ) -12.92 Million SEK 98.506%
Lipum AB (publ) 53 Thousand SEK 464.151%
BioInvent International AB (publ) 71.46 Million SEK 100.27%
Alzinova AB (publ) 19.87 Million SEK 100.971%
Oncopeptides AB (publ) 36.29 Million SEK 100.532%
Pila Pharma AB (publ) 1.46 Million SEK 113.192%
Guard Therapeutics International AB (publ) -15 Thousand SEK -1186.667%
Scandinavian ChemoTech AB (publ) 1.65 Million SEK 111.641%
Simris Alg AB (publ) 2 Million SEK 109.616%
Diamyd Medical AB (publ) -3.58 Million SEK 94.609%
Xbrane Biopharma AB (publ) 35.38 Million SEK 100.545%
Ascelia Pharma AB (publ) -1.04 Million SEK 81.602%
Diagonal Bio AB (publ) 3.13 Million SEK 106.16%